AstraZeneca PLC
Saphnelo
systemic lupus erythematosus
Resolved
187days ago
Phase 2 readout · Jan 1, 2026
What's at stake
Phase 2 trial results for Saphnelo in systemic lupus erythematosus are due Jan 1, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 6-K
verified 14h ago
“Full results from the TULIP-SC trial were published in Arthritis & Rheumatology in January 2026.”